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Abstract
BACKGROUND: Antioxidant gene polymorphism is one of the genetic risk factors associated with type 2 diabetes 
mellitus (T2DM) incidence.
AIM: This study was to analyze the association of superoxide dismutase 2 (SOD2) Ala16VAl, glutathione peroxidase 
(GPx1) Pro198Leu, glutathione S-transferase Pi1 (GSTP1) Ile105Val, and Cat −21 A/T gene polymorphisms and 
risk of T2DM.
METHODS: We genotyped deoxyribonucleic acid of 120 T2DM patients and 80 healthy control by polymerase chain 
reaction and restriction fragment length polymorphism method, using a specific restriction enzyme.
RESULTS: This study showed that the Val/Val of SOD2 was significantly associated with an increased risk of T2DM 
compared to the Ala/Ala+Ala/Val (p = 0.011; odds ratio [OR] = 2.220; confidence interval [CI] = 1.234–3.992). The TT 
genotype of Cat gene was also significantly associated with an increased risk of T2DM compared to the AA genotype 
(p = 0.027; OR = 5.000; CI = 1.079–23.176) and TT genotype to the AA+AT genotype (p = 0,030; OR = 4.738; 
CI = 1.039–21.600). However, there was no difference in all genetic models of GPx1 Pro198Leu and GSTP1 
Ile105Val gene polymorphisms (p > 0.05).
CONCLUSION: This study indicates that the Val/Val under the recessive model of SOD2 gene also TT genotype 
under the co-dominant model of Cat gene and TT genotype under the recessive model of Cat gene were associated 
with risk factors for T2DM occurrence.
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Introduction
Diabetes mellitus (DM) is a metabolic syndrome 
that occurs when the pancreas is unable to produce 
insulin or the insulin unable to work properly, results in 
hyperglycemia. Type 2 DM (T2DM) is the most common 
type of DM found in adults [1]. International Diabetes 
Federation in 2019 report the prevalence of adult 
population aged 20–79 years in the world suffering from 
T2DM reached 463 million. This number is expected to 
increase to 700 million by 2045. Moreover, Indonesia 
is the second-highest number of T2DM in the Western 
Pacific region, with 10.7 million [2]. In North Sumatra, 
the prevalence of people with T2DM was 1.7% in 2013 
and rose to 1.9% in 2018 [3].
Risk factors for the emergence of T2DM are 
genetic, environment, or interactions of both factors [1]. 
Antioxidants gene polymorphisms are one of the 
genetic risk factors associated with T2DM incidence. 
Single-nucleotide polymorphisms (SNPs) are the 
most common polymorphism of genetic variation in 
an individual. SNPs represent the difference of one 
nucleotide in the deoxyribonucleic acid (DNA) building 
block [4]. A previous study had shown the relationship 
of the antioxidant-superoxide dismutase 2 (SOD2) 
Ala16Val gene polymorphism with the incidence of 
T2DM [5]. SOD2 is present in the mitochondria. This 
enzyme gene is located on chromosome 6q25.3. Another 
study had shown a relationship between glutathione 
peroxidase (GPx1) Pro198Leu polymorphism and 
T2DM in populations in Poland [6]. Other antioxidant 
gene polymorphisms known to be associated with 
T2DM incidence are glutathione S-transferase Pi1 
(GSTP1) Ile105Val gene polymorphism and catalase 
(Cat) -21A/T [7], [8].
SOD2, GPx1, GSTP1, and Cat are endogenous 
antioxidant molecules that have a significant role in 
the elimination of reactive oxygen species (ROS). 
Polymorphisms in each of these genes contribute to 
the emergence of phenotypic differences when gene 
expression occurs, which affects the antioxidant levels/ 
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activity of eliminating ROS. Imbalance of antioxidants 
and ROS is thought to play a role in the occurrence of 
insulin resistance, which causes an increase in glucose 
levels [4], [9], [10].
The purpose of this study was to 
assess the association of SOD2 Ala16Val, GPx1 
Pro198Leu, GSTP1 Ile105Val, and Cat -21A/T gene 
polymorphisms and risk of T2DM. To the best of our 
knowledge, this study is the first to be conducted on 
an Indonesian population in the city of Medan, North 
Sumatra.
Materials and Methods
T2DM patients and healthy control 
subjects
The current case-control study was including 
T2DM patients and healthy control subjects. T2DM 
was diagnosed based on the criteria established by the 
Indonesian Endocrinologist Association [11], recruited at 
Endocrinology Polyclinic in Universitas Sumatera Utara 
(USU) Hospital and Padang Bulan Public Health Centers. 
A total of 120 T2DM patients were chosen based on the 
inclusion and exclusion criteria. The inclusion criteria 
were male or female aged 20-79 years, diagnosed with 
T2DM since 6 months ago, willing to participate as a 
research subject. The informed consent that has been 
approved by the Faculty of Medicine, USU-Haji Adam 
Malik General Hospital Ethics Committee No. 447/
KEPK FK USU-RSUP HAM/2019. The written informed 
consent for participation in this study was obtained 
from all subjects in accordance with the principles of 
the Declaration of Helsinki. The exclusion criteria were 
T2DM with obesity and other complications. A total 
of 80 subjects participated were randomly recruited 
among people in the Faculty of Medicine, USU staffs, 
and gym participants from several gyms in Medan 
city, North Sumatera Province. Inclusion criteria were 
male or female, with fasting blood glucose <126 mg/dl. 
However, subjects who have a history of malignant 
disease were excluded from this study. Characteristics 
of subjects, including age, gender, duration of diabetes, 
and smoking, were collected through interviews using 
questionnaires.
Blood glucose measurement
Blood glucose levels were measured using 
the Cobas 6000 analyzer with hexokinase and 
immunoturbidimetry method (Roche Diagnostics, 
Switzerland) at USU Hospital Laboratory.
Antioxidants genotyping
Analysis of antioxidants gene polymorphism 
was carried out in Molecular Biology Integrated 
Laboratory at the Medical Faculty of USU. DNA 
extraction from leukocyte obtained using a 
commercial Wizard Genomic DNA purification kit 
from Promega (USA). Polymerase chain reactions 
(PCR) of SOD2, GPx1, GSTP1, and Cat gene were 
performed using the thermal cycler. The primer pairs 
used for the antioxidants gene, PCR condition, and 
the respective restriction enzyme of the restriction 
fragment length polymorphism (RFLP) can be seen in 
Table 1.
Statistical analysis
The data were analyzed using SPSS version 19. 
Hardy-Weinberg equilibrium (HWE) of antioxidant genes 
in T2DM patients and healthy controls group were 
calculated using Chi-square goodness-of-fit test. A 
comparison of the mean values in the data between 
T2DM groups and control subjects was performed 
using non-paired t-tests. The 95% confidence intervals 
(CI) and odds ratios (ORs) were calculated to determine 
the statistical significance and risk of antioxidants 
gene polymorphisms to T2DM using the Chi-square 
test or Fisher’s exact test. p < 0.05 was considered as 
statistically significant.
Table 1: Primers, PCR conditions, PCR and RFLP products, and restriction enzymes
Genes Primer Sequence  (Macrogen, USA) PCR condition Restriction enzyme and 
temperature
PCR and RFLP product
SOD2 A1a6/Val 
(C/T)
(F) 5’-CAG CCC AGC CTG CGG AGA CGG-3’
(R) 5’-CTT GGC CAA CGC CTC CTG GTA CTT-3’
95°C 5 min., (95°C 45 s; 54°C 30 s; 
72°C 30 s) × 30, 72°C 5 min [12]
BsaW1 enzyme/30 min 65°C 
(Time-Saver Qualified enzyme. 
New England Biolabs, USA)
267 bp;
Ala/Ala (CC) = 267 bp 
Ala/Val (CT) = 267 bp, 183 bp, 84 bp 
Val/Val (TT) = 183 bp, 84 bp.
GPx1 
Pro198Leu 
(C/T)
(F) 5’- TCC AGA CCA TTG ACA TCG AG-3′
(R) 5’-ACT GGG ATC AAC AGG ACC AG-3′ 
94°C 8 min., (94°C 30s; 59°C 30 s; 
72 C 30 s) × 35, 72°C 7 min [12]
Apa1 enzyme/1 h 37°C (Promega, 
Madison, WI USA)
222 bp;
Pro/Pro (CC) = 170bp, 52 bp 
Pro/Leu (CT) = 222 bp, 170 bp, 52 bp 
Leu/Leu (TT) = 222 bp
GSTP1 
Ile105Val (A/G)
(F) 5’-GTA GTT TGC CCA AGG TCA AG-3’
(R) 5’-AGC CAC CTG AGG GGT AAG-3’
95°C 5 min., (94°C 45 s; 62°C 40 s; 
72°C 50 s) × 35, 72°C 7 min [13]
BsmAI enzyme/30 min 65°C 
(Time-Saver Qualified enzyme. 
New England Biolabs, USA)
433 bp
Ile/Ile (AA) =329 and 104 bp 
Ile/Val (AG) =329, 222, and 104 bp 
Val/Val (GG) =222 bp and 104 bp 
Catalase −21 
A/T
Forward primer 5′-AATCAGAAGGCAGTCCTCCC-3′
Reverse primer 5′-TCGGGGAGCACAGAGTGTAC-3′
95°C 4 min., (94°C 1m; 61ºC 40s;  
72°C 1 m) × 30, 72°C 5 min [14]
Hinf enzyme/1 h 37°C (Promega, 
Madison, WI USA)
250 bp;
AA = 250 bp
AT = 250, 177 and 73 bp
TT = 177 and 73 bp
SOD2: Superoxide dismutase 2, GPx1: Glutathione peroxidase, GSTP1: Glutathione S-transferase Pi1, PCR: Polymerase chain reaction, RFLP: Restriction fragment length polymorphism.
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Results
The characteristics of healthy and control 
T2DM patients groups in this study can be seen in 
Table 2.
Table 2: The characteristics of studied groups
Characteristic Healthy control T2DM p
Gender (n; %)
Male 34 (42.5%) 53 (44.2%) 0.885
Female 46 (57.5%) 67 (55.8%)
Age (years) 33.400 ± 15.972 57.000 ± 11.919 0.000
Duration of disease (years) - 7.041 ± 5.837 -
Smoking
No 64 (80.0%) 73 (60.8%) 0.005
Yes 16 (20.0%) 47 (39.2%)
Blood glucose (mg/dl) 113.925 ± 27.772 277.500 ± 103.300 0.000
T2DM: Type 2 diabetes mellitus.
There were no sex differences between the 
research subjects in the T2DM group and healthy 
controls (p > 0.05). The mean age of research subjects 
diagnosed with T2DM was higher than that of the control 
group (57.000 ± 11.919 vs. 33.400 ± 15.972; p = 0.000). 
There was a significant difference in smoking habits, 
glucose levels between the two groups (p < 0.05).
PCR and RFLP products of antioxidants 
polymorphism can be seen in Figures 1 and 2.
Figure 1: Polymerase chain reaction analysis of superoxide 
dismutase 2, glutathione peroxidase, glutathione S-transferase Pi1, 
and Cat gene
The results of antioxidants genotyping for 
T2DM patients and healthy controls subjects are 
summarized in Table 3.
This study showed that the Val/Val frequency 
of SOD2, Pro/Pro of GPx1, and TT genotype of Cat 
were the highest genotypes in the T2DM group and 
the control group (70.0%, 71.7%, 54.2% and 51.2%, 
73.8%, 62.5%), different results, the Ile/Val of GST1 
found highest in the T2DM group (49.2%), and Ile/Ile of 
GSTP1 Ile105Val was the highest in the control group 
(47.5%). The HWE analysis shows that the frequency 
distribution of SOD2 Ala16Val, GPx1 Pro198Leu, 
GSTP1 Ile105Val, and Cat −21 A/T genotypes in all 
groups was in agreement under the HWE law (p > 0.05).
The Val/Val of SOD2 was significantly 
associated with an increased risk of T2DM compared 
to the Ala/Ala+Ala/Val (p = 0.011; OR = 2.220; 
CI = 1.234– 3.992). The TT genotype of Cat gene was 
significantly associated also with an increased risk of 
T2DM compared to the AA genotype (p = 0.027; OR 
= 5.000; CI = 1.079-23.176) and TT genotype to the 
AA+AT genotype (p = 0,030; OR = 4.738; CI = 1.039-
21.600). However, there was no difference in all genetic 
models of GPx1 Pro198Leu and GSTP1 Ile105Val gene 
polymorphisms (p > 0.05) (Table 4).
Discussion
Endogenous antioxidants such as SOD2, 
GPx1, GSTP1, and Cat act as a complex and 
comprehensive protection system to deal with oxidative 
stress on cells. Oxidative stress is defined as an 
imbalance between ROS and the antioxidant defense 
system. ROS is free radicals in the form of oxygen 
and derivatives that are very reactive. Antioxidants 
have a molecular structure that can provide electron 
compounds to free radical molecules and can break 
the chain reaction of free radicals. The presence of 
polymorphisms in antioxidants is associated with a 
decrease in antioxidant activity to eliminate ROS, so it 
is associated with the risk of several diseases, including 
the risk of suffering from T2DM [9], [15], [16].
In this study, genotyping of SOD2 Ala16Val, 
GPx1 Pro198Leu, GSTP1 Ile105Val, and Cat −21 A/T 
gene variants have been carried out. The results of 
the Chi-square goodness-of-fit test analysis, which 
examined the distribution of genotype frequencies 
of all groups, were in agreement under the HWE law 
in accordance with the HWE law (p > 0.05). HWE is 
a mathematical relation model which states that a 
Table 3: Distribution of genotype of Ala16Val, GPx1 198Pro/
Leu, GSTP1 Ile105Val, and Catalase −21 A/T polymorphisms in 
studied groups and HWE test
Genes polymorphism Healthy control n (%) T2DM n (%) Total n (%)
SOD2 Ala16Val (C/T)
Ala/Ala (CC) 4 (5.0) 3 (2.5) 7 (3.5)
Ala/Val (CT) 35 (43.8) 33 (27.5) 68 (34.0)
Val/Val (TT) 41 (51.2) 84 (70.0) 125 (62.5)
C 43 (26.9) 39 (16.3) 82 (20.5)
T 117 (73.1) 201 (83.7) 318 (79.5)
HWE ; X2 (p) 0.013 (0.909) 1.023 (0.311) 0.371 (0.542)
GPx1 198Pro/Leu(C/T)
Pro/Pro (CC) 59 (73.8) 86 (71.7) 145 (72.5)
Pro/Leu (CT) 19 (23.8) 32 (26.7) 51 (25.5)
Leu/Leu (TT) 2 (2.5) 2 (1.7) 4 (2.5)
C 137 (85.6) 204 (85.0) 341(85.3)
T 23 (14.4) 36 (15.0) 59 (14.8)
HWE ; X2 (p) 0.251 (0.616) 0.099 (0.752) 0.039 (0.843)
GSTP1 Ile105Val (A/G)
Ile/Ile (AA) 38 (47.5) 53 (44.2) 91 (45.5)
Ile/Val (AG) 36 (45.0) 59 (49.2) 95 (47.5)
Val/Val (GG) 6 (7.5) 8 (6.7) 14 (7.0)
A 112 (70.0) 165 (68.8) 277 (69.3)
G 48 (30.0) 75 (31.3) 123 (30.8)
HWE ; X2 (p) 0.408 (0.522) 2.496 (0.114) 2.569 (0.310)
Cat −21 A/T
AA 50 (62.5) 65 (54.2) 115 (57.5)
AT 28 (35.0) 42 (35.0) 70 (35.0)
TT 2 (2.5) 13 (10.8) 15 (7.5)
A 128 (80.0) 172 (71.7) 300 (75.0)
T 32 (20.0) 68 (28.3) 100 (25.0)
HWE ; X2 (p) 2.290 (0.130) 0.703 (0.401) 0.888 (0.345)
T2DM: Type 2 diabetes mellitus, SOD2: Superoxide dismutase 2, Gpx1: Glutathione peroxidase, 
GSTP1: Glutathione S-transferase Pi1.
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genotype or allele frequency in a population will be 
constant from one generation to another, without the 
influence of evolution [17].
The results of the current study found that 
individuals with the Val/Val of SOD2 under the recessive 
model had 2.220 fold to the risk of T2DM compared to 
the Ala/Ala+Ala/Val (p = 0.011; OR = 2.220; CI = 1.234-
3.992). These study results are in line with previous 
studies, which also found an association between SOD2 
Ala16Val polymorphism and T2DM in Lucknow, India, 
and Lebanese populations [5], [18]. In contrast, different 
results were found in the Western Indian population [19].
SOD2 is present in the mitochondria. This 
enzyme gene is located on chromosome 6q25.3. SOD2 
Ala16Val (+ 47C/T) is the most common dimorphism 
found. The dimorphism of this gene is the substitution of 
nucleotide C to T at nucleotide 47 (GCT to GTT), in which 
the amino acid alanine changes to valine. The amino acid 
alanine changes to valine cause conformational changes 
of MTS from β-sheet to α-Helix. Val/Val or T allele of 
the SOD2 gene would encode a β-sheet conformation, 
arrested in the inner mitochondrial space, and degraded as 
proteasome leading to low mitochondrial-SOD activity [5]. 
This underpins the SOD2 Ala16Val polymorphism 
associated with the pathogenesis of several diseases. 
Increased Val/Val of the SOD2 gene or T allele causes 
less SOD ability to fight oxidative stress [20], [21].
In the present study, no significant relationship 
was found between GPx1 Pro198Leu and GSTP1 
Ile105Val in all genetic models (co-dominant, dominant, 
and recessive) with T2DM risk (p > 0.05). The GPx1 
polymorphism that has been identified is the substitution 
of cytosine to thymine (C > T), it causes the substitution 
of proline with leucine occurring in codon 198 in exon 
2 (Pro198Leu, rs1050450). The GSTP1 gene is one 
of the antioxidant gene located on the long arm of 
chromosome 11. In the GSTP1 Ile105Val (rs1695), the 
substitution of adenine to guanine (A/G) is found in the 
DNA coding sequence. This results in a substitution of 
isoleucine residue to valine (Ile/Val). Previous studies 
have shown that GPx1 Pro198Leu and GSTP1 Ile105Va 
are not related to the risk of T2DM, but these results are 
inconsistent [5], [7], [22], [23].
Analysis of the Cat −21 A/T gene shows a 
significant relationship between the TT genotype of 
Cat −21 A/T under the co-dominant model and the TT 
Cat −21 A/T under the recessive model with the risk 
of suffering from T2DM (OR = 5.000, 95% CI: 1.079-
23.176, p = 0.027 and OR = 4.738, 95% CI: 1.039–
21.600, p = 0.030). CAT is a homotetrameric protein with 
a mass of 224 kDa containing 527 amino acid residues, 
which have four heme groups in their structure. The gene 
is localized on chromosome 11p13.31, which consists of 
13 exons and 12 introns. The TT genotype in Cat −21 
A/T gene polymorphism can affect CAT production or 
activity because of its ability to change binding affinity at 
the transcription factor area. The decreased activity of 
CAT can increase oxidative stress that causes damage 
to a certain gene, trigger many diseases [8], [24].
Several previous researchers have investigated 
the relationship between the −21 A/T polymorphism and 
Figure 2: Restriction fragment length polymorphism analysis of (A) Ala16Val; (B) glutathione peroxidase 198Pro/Leu; (C) glutathione 
S-transferase Pi1 Ile105Val; and (D) Catalase −21 A/T polymorphisms
dc
ba
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the risk of T2DM. Research by Saravani et al. (2015) 
on T2DM populations in Iran found that TT genotype of 
Cat −21 was associated with a risk of T2DM occurrence 
of 1797 times. Other studies by Vat et al. (2013) in the 
Lucknow population, India, found that Cat −21 A/T 
genotypes are associated with T2DM but not Cat −21 
A/T alleles [8], [25]. A different result that Cat −21 A/T 
polymorphism is not related to T2DM in populations in 
the Czech Republic [26].
In humans, genes that play a role in coding 
antioxidants are known to be highly polymorphic 
cause gene variation. Race and ethnicity are known 
to affect individual gene variations. The association 
between genotype or allele of single-nucleotide 
polymorphisms and several diseases is also known 
to vary according to race or ethnicity. The association 
between ethnicity and diseases or susceptibility 
of the disease has been reported in several 
previous studies. The existence of racial and ethnic 
differences is a factor that allows differences in the 
results of this study with previous research in various 
populations [27], [28].
Conclusion
This study indicates that the Val/Val in the 
recessive model of SOD2 gene also TT genotype in 
the co-dominant model of Cat gene and TT genotype 
in the recessive model of Cat gene are associated with 
risk factors for T2DM occurrence. However, this was 
not found in GPx1 Pro198Leu and GSTP1 Ile105Val. 
The limitations of this study were the small number 
of samples and examination of antioxidant serum’s 
activity/levels of subjects was not performed. Further 
research is needed on larger samples and analyzing 
the relationship of antioxidant variants with antioxidant 
activity/levels of subjects.
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